rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
5
|
pubmed:dateCreated |
2001-6-5
|
pubmed:abstractText |
To increase pulmonary deposition of anticancer liposome aerosols in mice by modulation of respiratory physiology through the addition of 5% CO2 to the air source used to generate the aerosols. Breathing CO2-enriched aerosol increases pulmonary ventilation with concurrent increased deposition of inhaled particles.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
0344-5704
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
47
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
451-6
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:11391862-Administration, Inhalation,
pubmed-meshheading:11391862-Animals,
pubmed-meshheading:11391862-Antineoplastic Agents, Phytogenic,
pubmed-meshheading:11391862-Camptothecin,
pubmed-meshheading:11391862-Carbon Dioxide,
pubmed-meshheading:11391862-Chromatography, High Pressure Liquid,
pubmed-meshheading:11391862-Drug Delivery Systems,
pubmed-meshheading:11391862-Liposomes,
pubmed-meshheading:11391862-Mice,
pubmed-meshheading:11391862-Mice, Inbred ICR,
pubmed-meshheading:11391862-Paclitaxel
|
pubmed:year |
2001
|
pubmed:articleTitle |
Improved respiratory delivery of the anticancer drugs, camptothecin and paclitaxel, with 5% CO2-enriched air: pharmacokinetic studies.
|
pubmed:affiliation |
Department of Molecular Physiology and Biophysics, Baylor College of Medicine, Houston, TX 77030, USA. koshkina@bcm.tmc.edu
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|